Equities

Coeptis Therapeutics Holdings Inc

COEP:NAQ

Coeptis Therapeutics Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.1851
  • Today's Change0.010 / 5.47%
  • Shares traded284.49k
  • 1 Year change-81.30%
  • Beta-0.8921
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Coeptis Therapeutics Holdings Inc fell by 2.32m. Cash Flow from Financing totalled 4.92m or -- of revenues. In addition the company used 7.24m for operations while cash from investing was breakeven.
Cash flow per share-0.4532
Price/Cash flow per share--
Book value per share-0.0111
Tangible book value per share-0.0111
More ▼

Balance sheet in USDView more

Coeptis Therapeutics Holdings Inc has a Debt to Total Capital ratio of 122.25%, a higher figure than the previous year's 7.65%.
Current ratio0.5491
Quick ratio--
Total debt/total equity--
Total debt/total capital1.22
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.